In addition, FGF21 might inhibit hepatic expression of sterol regulatory element-binding protein 2 and increase adiponectin levels, then effectively improved atherosclerosis and prevented obesity-related metabolic heart disease (27, 28). Here, SREBF2 is linked to obesity due to melanocortin 4 receptor deficiency.